12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Illumigene Group B Streptococcus regulatory update

FDA granted 510(k) clearance to Meridian's illumigene Group B Streptococcus (GBS) molecular assay. Meridian plans to launch...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >